Technical Analysis for MRKR - Marker Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 5.89 -0.17% -0.01
MRKR closed down 0.17 percent on Thursday, January 17, 2019, on 81 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MRKR trend table...

Date Alert Name Type % Chg
Jan 17 Outside Day Range Expansion 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 16 NR7 Range Contraction -0.17%
Jan 16 Wide Bands Range Expansion -0.17%
Jan 15 20 DMA Support Bullish 3.88%
Jan 15 Wide Bands Range Expansion 3.88%
Jan 14 Outside Day Range Expansion 0.17%
Jan 14 Wide Bands Range Expansion 0.17%
Jan 11 NR7 Range Contraction -0.34%
Jan 11 Inside Day Range Contraction -0.34%

Older signals for MRKR ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its cell therapy technology is based on the tumor-specific T cells that recognize tumor associated antigens and kill tumor cells expressing those targets. The company is also advancing various peptide- and gene-based immuno-therapeutics for the treatment of cancer and metastatic disease, including its Folate Receptor Alpha program (TPIV200) for breast and ovarian cancers and HER2/neu+ peptide antigen program (TPIV100/110) in Phase II clinical trials. In addition, it develops a proprietary DNA expression technology, known as PolyStart, to improve the ability of the cellular immune system to recognize and destroy diseased cells. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
Is MRKR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 13.55
52 Week Low 2.58
Average Volume 229,635
200-Day Moving Average 6.9348
50-Day Moving Average 6.4284
20-Day Moving Average 5.523
10-Day Moving Average 6.107
Average True Range 0.5509
ADX 16.74
+DI 21.9927
-DI 22.4219
Chandelier Exit (Long, 3 ATRs ) 5.4473
Chandelier Exit (Short, 3 ATRs ) 5.8327
Upper Bollinger Band 7.1389
Lower Bollinger Band 3.9071
Percent B (%b) 0.61
BandWidth 58.5153
MACD Line -0.1212
MACD Signal Line -0.1959
MACD Histogram 0.0747
Fundamentals Value
Market Cap 59.83 Million
Num Shares 10.2 Million
EPS -1.02
Price-to-Earnings (P/E) Ratio -5.77
Price-to-Sales 0.00
Price-to-Book 3.74
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.49
Resistance 3 (R3) 6.50 6.31 6.39
Resistance 2 (R2) 6.31 6.16 6.31 6.36
Resistance 1 (R1) 6.10 6.06 6.01 6.09 6.32
Pivot Point 5.91 5.91 5.86 5.91 5.91
Support 1 (S1) 5.70 5.76 5.61 5.69 5.46
Support 2 (S2) 5.51 5.66 5.51 5.42
Support 3 (S3) 5.30 5.51 5.39
Support 4 (S4) 5.29